Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection just once a month.
Search results for "obesity drug"
Taking Wegovy or Mounjaro? Seek Immediate Medical Attention if ‘These Symptoms’ Appear
As anti-obesity medications for weight loss and blood sugar control gain popularity, monitoring and managing potential side effects has become...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
6 out of 10 Diet Pill Users Say They Take It to Lose Weight Even Though They Are Not Obese
About 60% of those taking medication to suppress appetite are reported to not be obese.
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight. " This is a common phrase heard when visiting a hospital for knee pain.
GLP-1 Drugs and Bone Health: Studies Highlight Fracture Risks in Elderly Patients
The GLP-1 receptor agonist class of drugs, widely used for the treatment of obesity and type 2 diabetes, has...
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity
It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.